These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 26826652)
1. Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein. Hong SY; Yu FX; Luo Y; Hagen T Cell Signal; 2016 May; 28(5):377-383. PubMed ID: 26826652 [TBL] [Abstract][Full Text] [Related]
2. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease. Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988 [TBL] [Abstract][Full Text] [Related]
3. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism. Liu Y; Zhao Y; Guo L Mol Cell Endocrinol; 2016 Jan; 420():208-16. PubMed ID: 26549689 [TBL] [Abstract][Full Text] [Related]
4. Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma. Makinoshima H; Takita M; Saruwatari K; Umemura S; Obata Y; Ishii G; Matsumoto S; Sugiyama E; Ochiai A; Abe R; Goto K; Esumi H; Tsuchihara K J Biol Chem; 2015 Jul; 290(28):17495-504. PubMed ID: 26023239 [TBL] [Abstract][Full Text] [Related]
5. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes. Veilleux A; Houde VP; Bellmann K; Marette A Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102 [TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure. Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586 [TBL] [Abstract][Full Text] [Related]
7. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways. Yang L; Hou Y; Yuan J; Tang S; Zhang H; Zhu Q; Du YE; Zhou M; Wen S; Xu L; Tang X; Cui X; Liu M Oncotarget; 2015 Sep; 6(28):25755-69. PubMed ID: 26342198 [TBL] [Abstract][Full Text] [Related]
9. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism. Ellis BC; Graham LD; Molloy PL Biochim Biophys Acta; 2014 Feb; 1843(2):372-86. PubMed ID: 24184209 [TBL] [Abstract][Full Text] [Related]
10. Roles of glucose transporter-1 and the phosphatidylinositol 3‑kinase/protein kinase B pathway in cancer radioresistance (review). Fang J; Zhou SH; Fan J; Yan SX Mol Med Rep; 2015 Mar; 11(3):1573-81. PubMed ID: 25376370 [TBL] [Abstract][Full Text] [Related]
11. Selenium deficiency-induced thioredoxin suppression and thioredoxin knock down disbalanced insulin responsiveness in chicken cardiomyocytes through PI3K/Akt pathway inhibition. Yang J; Hamid S; Cai J; Liu Q; Xu S; Zhang Z Cell Signal; 2017 Oct; 38():192-200. PubMed ID: 28734787 [TBL] [Abstract][Full Text] [Related]
12. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463 [TBL] [Abstract][Full Text] [Related]
13. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631 [TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of TXNIP by AKT Mediates Acute Influx of Glucose in Response to Insulin. Waldhart AN; Dykstra H; Peck AS; Boguslawski EA; Madaj ZB; Wen J; Veldkamp K; Hollowell M; Zheng B; Cantley LC; McGraw TE; Wu N Cell Rep; 2017 Jun; 19(10):2005-2013. PubMed ID: 28591573 [TBL] [Abstract][Full Text] [Related]
15. The Regulation of Lipid Deposition by Insulin in Goose Liver Cells Is Mediated by the PI3K-AKT-mTOR Signaling Pathway. Han C; Wei S; He F; Liu D; Wan H; Liu H; Li L; Xu H; Du X; Xu F PLoS One; 2015; 10(5):e0098759. PubMed ID: 25945932 [TBL] [Abstract][Full Text] [Related]
16. EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line. Nishimura Y; Takiguchi S; Ito S; Itoh K Int J Oncol; 2015 Apr; 46(4):1721-9. PubMed ID: 25653196 [TBL] [Abstract][Full Text] [Related]
17. D-Allose Inhibits Cancer Cell Growth by Reducing GLUT1 Expression. Noguchi C; Kamitori K; Hossain A; Hoshikawa H; Katagi A; Dong Y; Sui L; Tokuda M; Yamaguchi F Tohoku J Exp Med; 2016 Feb; 238(2):131-41. PubMed ID: 26829886 [TBL] [Abstract][Full Text] [Related]
18. AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake. Rashmi R; DeSelm C; Helms C; Bowcock A; Rogers BE; Rader JL; Rader J; Grigsby PW; Schwarz JK PLoS One; 2014; 9(4):e92948. PubMed ID: 24705275 [TBL] [Abstract][Full Text] [Related]